How to Get Soolantra Online in Munich
Looking for Soolantra online in Munich? Complete an online medical review for 40 €. An EU-licensed doctor reviews your case in under 24 hours with prescription options.
DIRECT ANSWER
An online consultation lets an EU-licensed doctor review your case and, if appropriate, issue a prescription that is valid across the EU.
Less than 4 hours on average
Prescription issued in less than 4 hours on average if approved.
EU-licensed doctors
Every case is reviewed by a licensed clinician.
Valid across the EU
Approved prescriptions can be used at any EU pharmacy.
In this article
Adults looking to get Soolantra online in Munich can access professional clinical evaluation from home rather than waiting months for an in-person dermatology appointment. While Hi-Doctor does not prescribe the standalone brand Soolantra (ivermectin 1% monotherapy), our EU-licensed doctors evaluate rosacea presentations and prescribe evidence-based topical treatments when clinically indicated. These options include a multi-action compounded papulopustular gel containing ivermectin 1%, metronidazole 0.75%, and niacinamide 2%.
Through a secure medical questionnaire and photo upload, a doctor reviews within 24 hours and issues a prescription when clinically appropriate. The service costs a 40 € one-off consultation fee. If the reviewing physician determines that digital topical treatment is unsuitable for your condition, the 40 EUR consultation fee is refunded in full if the doctor does not issue a prescription.
Over 50,000 patients have accessed asynchronous medical consultations through Hi-Doctor, backed by a 4.8/5 Trustpilot rating across the European Union.
Key takeaways
- Targeted formulary: Hi-Doctor does not prescribe standalone Soolantra, offering instead targeted compounded formulations (ivermectin 1% + metronidazole 0.75% + niacinamide 2%) or azelaic acid 15% gel for papulopustular rosacea.
- Asynchronous clinical review: Complete a dynamic questionnaire and upload clear skin photos without needing a video call or clinic visit.
- Fast medical turnaround: An EU-licensed doctor evaluates your submission and issues a digital prescription in under 24 hours when clinically appropriate.
- EU-wide cross-border standard: Approved prescriptions are issued via Spain's official REMPE electronic format in downloadable PDF form.
- Refund policy: The 40 EUR consultation fee is refunded in full if the doctor does not issue a prescription.
How it works — get your consultation in 4 steps
Accessing rosacea care online in Munich takes only a few minutes from any smartphone or computer.
- Complete the clinical questionnaire: Answer branching medical questions detailing your rosacea history, previous treatments, known triggers, and current medications.
- Upload clear facial photos: Provide high-resolution photographs of the affected areas in natural light. This enables the physician to assess erythema distribution, lesion counts, and skin barrier status accurately.
- Doctor evaluation: An EU-licensed doctor reviews your case within 24 hours to determine clinical suitability for topical therapy.
- Prescription issuance and pharmacy presentation: If approved, your REMPE private electronic prescription is instantly downloadable as a PDF in your secure patient portal and sent via email notification. You can present the PDF on your phone or as a printout at any local pharmacy in Munich, where the pharmacist reviews the prescription and may dispense the medication.
Who qualifies
Online dermatology consultations are designed for adults experiencing mild to moderate facial rosacea that can be safely managed with prescription topical agents.
You may qualify for an online rosacea consultation if you meet the following criteria:
- You are at least 18 years of age and residing in Munich or elsewhere in the EU.
- You have persistent facial redness, inflammatory papules, or pustules across the central face (cheeks, nose, forehead, chin).
- You are not currently pregnant or breastfeeding (certain active ingredients carry specific contraindications).
- You do not exhibit signs requiring urgent in-person secondary care.
Clinical exclusions: Hi-Doctor provides topical treatments only. We do not prescribe oral isotretinoin or oral antibiotics. Patients with ocular rosacea (eye pain, gritty sensation, photophobia), rhinophyma (tissue hypertrophy of the nose), or severe cystic lesions are referred to in-person specialist clinics.
What Soolantra actually does
Soolantra contains 1% ivermectin, an antiparasitic and anti-inflammatory compound. In rosacea management, ivermectin works primarily by reducing the density of microscopic Demodex folliculorum mites inhabiting the pilosebaceous units, while simultaneously downregulating pro-inflammatory cytokines.
Because rosacea involves multiple overlapping pathological processes—including vascular hyperreactivity, barrier disruption, and microbial colonization—Hi-Doctor's clinical formulary employs compounded formulations that combine synergistic active ingredients rather than single-agent Soolantra.
| Formulation | Active Ingredients | Primary Clinical Target | Typical Application |
|---|---|---|---|
| Compounded Papulopustular Gel | Ivermectin 1% + Metronidazole 0.75% + Niacinamide 2% | Demodex reduction, bacterial suppression, and skin barrier repair | Once daily in the evening |
| Compounded Erythema Cream | Metronidazole 0.75% + Niacinamide 4% + Azelaic Acid 10% + Allantoin 0.5% | Persistent background redness, inflammation, and soothing | Twice daily |
| Azelaic Acid 15% Gel | Azelaic Acid 15% (Skinoren / Finacea) | Comedolytic, anti-inflammatory, and reduction of inflammatory papules | Twice daily |
| Soolantra (Off-Formulary Reference) | Ivermectin 1% alone | Demodex mite reduction (not prescribed by Hi-Doctor) | Once daily |
Rosacea is a chronic relapsing condition that is controlled rather than permanently cured. Visible improvement typically appears between weeks 4 and 8 of consistent topical application, with optimal therapeutic control achieved around week 12. Identifying and avoiding environmental triggers (such as UV radiation, alcohol, hot beverages, spicy foods, and temperature extremes) is essential to maintain remission.
Side effects and when to stop
Prescription topicals for rosacea are generally well tolerated, but localized skin reactions can occur during the initial weeks of therapy.
- Common, mild reactions: Transient stinging, mild burning sensation, localized erythema, and cutaneous dryness. These symptoms often subside as the epidermal barrier adapts.
- Temporary flare (Demodex die-off): A brief increase in inflammatory bumps during the first two weeks can occur as Demodex populations decrease.
- When to discontinue: Stop applying the medication and consult a healthcare provider if you experience severe contact dermatitis, swelling of the face or eyelids, intense pruritus, or vesicular eruptions.
Why Hi-Doctor vs. walking into a clinic
Securing an appointment with a statutory or private dermatologist in Munich often involves waiting lists extending from six to twelve weeks. Hi-Doctor offers an efficient, direct pathway to medical evaluation without waiting rooms or travel.
Under EU Directive 2011/24/EU, prescriptions issued by licensed medical practitioners in one EU Member State can be presented in another, containing mandatory data elements detailed in Implementing Directive 2012/52/EU.
When our doctors approve a treatment, a Spanish REMPE (Receta Médica Privada Electrónica) private prescription PDF is generated. It can be presented at any EU pharmacy, where the pharmacist reviews the document and may dispense the medication or an authorized domestic equivalent. Pharmacists retain professional discretion regarding dispensing under local regulations.
All personal and medical data is handled under strict GDPR compliance, ensuring complete confidentiality throughout your treatment pathway.
COMMON QUESTIONS
Frequently asked questions
No. Hi-Doctor's medical team does not prescribe standalone Soolantra (ivermectin 1%). Instead, our doctors prescribe evidence-based alternatives such as compounded gels combining ivermectin 1%, metronidazole 0.75%, and niacinamide 2%, or azelaic acid 15% gel when clinically indicated.
